Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02324153 · ClinicalTrials.gov registry record · Phase 2
Ramelteon in the Prevention of Post-operative Delirium
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT02324153: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT02324153 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02324153, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
This trial focuses on a Phase II randomized masked clinical trial testing the effectiveness and safety of peri-operative administration of ramelteon, a melatonin agonist in the prevention of postoperative delirium.
Interventions
- DRUG Ramelteon
- DRUG Microcrystalline Cellulose
- DRUG Riboflavin 100 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2017-03-24 |
| Est. Completion | 2019-06-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02324153
The ClinicalTrials.gov registry entry for NCT02324153 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ramelteon is the first listed.
NCT02324153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02324153 about?
NCT02324153 is a clinical study titled "Ramelteon in the Prevention of Post-operative Delirium". This trial focuses on a Phase II randomized masked clinical trial testing the effectiveness and safety of peri-operative administration of ramelteon, a melatonin agonist in the prevention of postoperative delirium.
What is the current status of trial NCT02324153?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2017-03-24. Estimated completion is 2019-06-26.
What interventions are being tested in trial NCT02324153?
The interventions under investigation include: Ramelteon (DRUG), Microcrystalline Cellulose (DRUG), Riboflavin 100 mg (DRUG).
Who is sponsoring clinical trial NCT02324153?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.